244 related articles for article (PubMed ID: 15014204)
1. Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists.
Reeves R; Thiruchelvam M; Cory-Slechta DA
Toxicol Sci; 2004 May; 79(1):123-36. PubMed ID: 15014204
[TBL] [Abstract][Full Text] [Related]
2. Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
Reeves R; Thiruchelvam M; Cory-Slechta DA
Brain Res; 2004 May; 1008(2):155-67. PubMed ID: 15145752
[TBL] [Abstract][Full Text] [Related]
3. The effect of developmental exposure to the fungicide triadimefon on behavioral sensitization to triadimefon during adulthood.
Reeves R; Thiruchelvam M; Richfield EK; Cory-Slechta DA
Toxicol Appl Pharmacol; 2004 Oct; 200(1):54-63. PubMed ID: 15451308
[TBL] [Abstract][Full Text] [Related]
4. Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon.
Reeves R; Thiruchelvam M; Richfield EK; Cory-Slechta DA
Pharmacol Biochem Behav; 2003 Sep; 76(2):315-26. PubMed ID: 14592684
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and neurochemical effects of acute and repeated administration of triadimefon in the male rat.
Ikaiddi MU; Akunne HC; Soliman KF
Neurotoxicology; 1997; 18(3):771-80. PubMed ID: 9339824
[TBL] [Abstract][Full Text] [Related]
6. Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
Del Arco A; Segovia G; Mora F
Psychopharmacology (Berl); 2008 Dec; 201(3):325-38. PubMed ID: 18751970
[TBL] [Abstract][Full Text] [Related]
7. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
[TBL] [Abstract][Full Text] [Related]
8. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors.
Christoffersen CL; Meltzer LT
Neuroscience; 1995 Jul; 67(2):373-81. PubMed ID: 7545793
[TBL] [Abstract][Full Text] [Related]
9. The neurochemical basis for the behavioral effects of triadimefon.
Hill D; Ikaiddi M; Mazzio E; Soliman KF
Ann N Y Acad Sci; 2000 Sep; 914():336-53. PubMed ID: 11085334
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
Starr MS; Starr BS
Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
[TBL] [Abstract][Full Text] [Related]
11. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats.
Pollack AE; St Martin JL; MacPherson AT
Synapse; 2005 Apr; 56(1):45-53. PubMed ID: 15700284
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
Zornoza T; Cano-Cebrián MJ; Miquel M; Aragón C; Polache A; Granero L
Neuropsychopharmacology; 2005 May; 30(5):843-52. PubMed ID: 15689964
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.
Kretschmer BD
J Neurochem; 1999 Aug; 73(2):839-48. PubMed ID: 10428083
[TBL] [Abstract][Full Text] [Related]
14. Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio.
Papathanou M; Creed M; Dorst MC; Bimpisidis Z; Dumas S; Pettersson H; Bellone C; Silberberg G; Lüscher C; Wallén-Mackenzie Å
Front Neural Circuits; 2018; 12():64. PubMed ID: 30210305
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
Mattingly BA; Himmler C; Bonta T; Rice LL
Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
[TBL] [Abstract][Full Text] [Related]
16. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.
Li Y; Vartanian AJ; White FJ; Xue CJ; Wolf ME
Psychopharmacology (Berl); 1997 Dec; 134(3):266-76. PubMed ID: 9438676
[TBL] [Abstract][Full Text] [Related]
17. Dopamine-glutamate interplay in the ventral striatum modulates spatial learning in a receptor subtype-dependent manner.
Coccurello R; Oliverio A; Mele A
Neuropsychopharmacology; 2012 Apr; 37(5):1122-33. PubMed ID: 22218092
[TBL] [Abstract][Full Text] [Related]
18. Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine.
Mattingly BA; Hart TC; Lim K; Perkins C
Psychopharmacology (Berl); 1994 Mar; 114(2):239-42. PubMed ID: 7838914
[TBL] [Abstract][Full Text] [Related]
19. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
20. Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(-/-) mice.
Dong Y; Saal D; Thomas M; Faust R; Bonci A; Robinson T; Malenka RC
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14282-7. PubMed ID: 15375209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
